Detail Data
Volume (24h): 313,502 shares
P/E Ratio: 23.31
Forward P/E: 24.43
EPS: 13.09 USD
Forward EPS: 12.49 USD
Number of Shares: 28,741,600 shares
Market Capitalization: 8,769,349,632.00 USD

Dividend

Dividend Value
Dividend Amount According to our data, the company Medpace does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a hold recommendation for Medpace stock. The current number of analysts covering this company is 11. The highest target price is 342 USD, while the lowest target price is 270 USD. The median target valuation set by analysts is 298.31 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Medpace.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Medpace stock is: hold
Number of Analysts: 11
Highest Target Price: 342 USD
Lowest Target Price: 270 USD
Median Target Price: 298.31 USD

Fundamental Indicators

Indicator Data
Total Revenue: 2,156,580,096.00 USD
Net Income: 416,391,008.00 USD
Price-to-Book (P/B): 15.30
PEG Ratio: /
Exchange: NasdaqGS
Industry: Diagnostics & Research
Sector: Healthcare
Number of Employees: 5900
Country: United States

Where to Buy Medpace Stock?

You can purchase Medpace stock on the NasdaqGS under the ticker symbol: MEDP. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Medpace Stock

Indicator Value
Company Revenue: 2,156,580,096.00 USD
EBITDA: 485,512,992.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share: 13.09 USD
Book Value Per Share: 19.94 USD
Total Cash: 441,436,000.00 USD
Total Cash per Share: 15.36 USD
Total Debt: 150,348,992.00 USD
Debt to Equity Ratio: 0.25
Quick Ratio 0.66
Current Ratio 0.73
Free Cash Flow 433,280,512.00 USD
Operating Cash Flow 581,974,016.00 USD
Gross Margins 68.08 %
EBITDA Margins 22.51 %
Operating Margins 20.32 %
Profit Margins 19.31 %
Return on Assets 15.4 %
Return on Equity 65.8 %
Earnings Growth (1 year) 14.7%
Revenue Growth (1 year) 9.3 %
Quarterly Earnings Year-over-Year Growth 11.7 %
Market Capitalization 8,769,349,632.00 USD
Enterprise Value 8,478,265,344.00 USD
EV/Revenue 3.931
EV/EBITDA 17.462
Float Shares 22,546,643 shares
Shares Outstanding 28,741,600 shares
Held Percent Insiders 0.21 %
Held Percent Institutions 91.81 %
Shares Short 2,032,431
Shares Short Prior Month 1,242,942
Date Short Interest 2025-04-15
Short Percentage of Total Shares 6.81 %
Short Ratio 3.80
Beta 1.46
Short Percentage of Float 8.49 %
Implied Shares Outstanding 28,741,600

Frequently Asked Questions (FAQ)

According to our data, the company Medpace does not pay dividends yet, even in 2025.

Medpace shares are traded on the NasdaqGS stock exchange under the ticker: MEDP. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for Medpace shares is from a total of 11 analysts. The average target price prediction is 298.31 USD per share.

The total number of Medpace shares on the exchange is 28,741,600.00 shares, which at the current market capitalization gives the company a total valuation of 8,769,349,632.00 USD.